0034-7434

S0034-74342020000300003

10.18597/rcog.3547

00 09 2020

71 3 247 256

FIGO Working Group on Menstrual Disorders 2011 113 1 1

3-13

2018 143 3 3

393-408

1999 106 7 7

623-32

2007 87 3 3

466-76

2007 22 3 3

635-6

2017 124 2 2

185-9

National Institute for Health and Care Excellence (NICE)

2018

2003 79 4 4

963-9

2006 108 4 4

924-9

2011 158 2 2

124-34

2019 9

CD000400

ACOG. Committee opinion

2014 123 603 603

1403-7

2014

2003 56 4 4

305-7

Bayer HealthCare Pharmaceuticals Inc 2014

1-193

2009 5 1 1

561-74

2020 6

CD002126

2013 368 2 2

184-5

De Sá Rosa-E-Silva ACJ.Yela DA.Júnior JMS 2017 39 7 7

358-68

2017 24 5 5

1322-9

Food and Drug Administration (FDA)

2016 8

589-98

2007 75 6^sSuppl 6^sSuppl Suppl

S2-7

2003 79 5 5

1194-8

2007 75 3 3

193-8

2010 94 1 1

371-4

2008 15 6 6

735-8

2011 95 2 2

497-502

2012 91 1 1

3-9

2012 3 1 1

1998 316 7138 7138

1122-6

2003 2 2

CD003855

2004 291 12 12

1456-63

1991 164 3 3

879-83

2009 31 4 4

340-7

2011 16 2 2

126-34

2011 204 2 2

126

2005 105 4 4

811-5

2008 90 3 3

673-7